Company Filing History:
Years Active: 2012-2015
Title: Innovations and Contributions of Cliff C Cheng
Introduction
Cliff C Cheng is a notable inventor based in Cambridge, MA, with a significant portfolio of seven patents. His work primarily focuses on the development of novel compounds and methods that address various medical conditions.
Latest Patents
Among his latest patents, Cheng has developed Anilinopiperazine derivatives and methods of use thereof. This invention relates to novel Anilinopiperazine Derivatives of Formula (I), which are utilized in compositions for treating or preventing a range of disorders, including cancer, inflammation, and cardiovascular diseases. Another significant patent involves inhibitors of fatty acid binding protein (FABP). This invention introduces novel heterocyclic compounds that serve as FABP inhibitors, aimed at treating cardiovascular diseases, metabolic disorders, and obesity-related conditions.
Career Highlights
Cheng has had a distinguished career, contributing to major pharmaceutical companies such as Merck Sharp & Dohme Corporation and Schering Corporation. His work in these organizations has been pivotal in advancing medical research and developing innovative treatments.
Collaborations
Throughout his career, Cheng has collaborated with esteemed colleagues, including Gerald Wayne Shipps, Jr. and Xiaohua Huang. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Cliff C Cheng's contributions to the field of medicine through his patents and collaborations highlight his role as a significant inventor. His innovative work continues to impact the treatment of various medical conditions, showcasing the importance of research and development in healthcare.